Maraganore wins best biopharma CEO vote; Vounatsos tops worst list
STAT readers have once again crowned the best and worst biopharma CEOs of the year — and it’s an all-Cambridge, Mass., pairing.
STAT readers have once again crowned the best and worst biopharma CEOs of the year — and it’s an all-Cambridge, Mass., pairing.
Drugmakers — major beneficiaries of NIH-backed university research — have been largely silence on the Trump administration’s cuts to agency research payments.
Understand the rapidly changing nature of AI in health and medicine with health tech reporter Brittany Trang in conversation with investigative reporter Casey Ross.
For World Cancer Day, get your 50% off your year of STAT+ and stay up-to-date on the latest trends and ground breaking discoveries in cancer…
Early diagnosis and treatment of ADHD could help prevent young people from picking up smoking, per a new study.
Artificial intelligence could be used to prescribe medications to patients — if a new bill makes its way through Congress
A federal judge issued a nationwide temporary pause on plans by the NIH to substantially slash research overhead payments
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! I haven’t even cleaned
As health secretary, Kennedy could revive a defunct task force to scrutinize the safety of shots given to babies and kids.
In this adapted excerpt from his new book “Doctored: Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid…